GCP
IDXX icon

Garda Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Garda Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,358
Closed -$649K – 607
2025
Q1 		$570K Buy
+1,358
New +$590K 0.01% 517
2023
Q4 		– Sell
-1,858
Closed -$872K – 572
2023
Q3 		$812K Buy
+1,858
New +$927K 0.04% 423

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Garda Capital Partners's IDXX Position: Q2 2025 in Review

Garda Capital Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 1,358 shares — an estimated $649K sold.

Garda Capital Partners first reported a position in IDXX in Q3 2023 and held it in 2 quarters. The position peaked at $812K in Q3 2023. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Garda Capital Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Garda Capital Partners sold 1,358 Idexx Laboratories shares in Q2 2025, an estimated $649K.
  • Garda Capital Partners first reported a position in Idexx Laboratories in Q3 2023 and held it in 2 quarters.
  • Garda Capital Partners's Idexx Laboratories position peaked at $812K in Q3 2023.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Garda Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.